The estimated Net Worth of Edward A Ogunro is at least 380 千$ dollars as of 24 November 2009. Edward Ogunro owns over 1,000 units of Luminex Corp stock worth over 200,634$ and over the last 15 years he sold LMNX stock worth over 0$. In addition, he makes 178,984$ as Lead Independent Director at Luminex Corp.
Edward has made over 1 trades of the Luminex Corp stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of LMNX stock worth 13,780$ on 24 November 2009.
The largest trade he's ever made was buying 1,000 units of Luminex Corp stock on 24 November 2009 worth over 13,780$. On average, Edward trades about 67 units every 0 days since 2009. As of 24 November 2009 he still owns at least 5,424 units of Luminex Corp stock.
You can see the complete history of Edward Ogunro stock trades at the bottom of the page.
Dr. Edward A. Ogunro Ph.D. serves as Lead Independent Director of the Company. Dr. Ogunro has served as a member of our Board of Directors since May 2009. Dr. Ogunro served as senior vice president, R&D and medical affairs and chief scientific officer at Hospira Inc., a global specialty pharmaceutical and medication delivery company, from April 2004 until December 2007. Prior to Abbott Laboratories’ (“Abbott”), a global, broad-based healthcare company, spin-off of Hospira in 2004, Dr. Ogunro served in a number of leadership positions for over 20 years with Abbott, primarily in Abbott’s Diagnostics Division, and most recently served as corporate vice president, R&D, medical and regulatory affairs in Abbott’s Hospital Products Division. He held numerous other positions with Abbott, including program director for AxSym and divisional vice president for Abbott’s Immunodiagnostics and Chemistry R&D Organization. Dr. Ogunro served on the board of directors of the Myeloproliferative Neoplasms Research Foundation (a not for profit organization). Previously, Dr. Ogunro pursued postdoctoral studies and served as an assistant professor at Northwestern University Medical School in Chicago from 1977 to 1982. Dr. Ogunro holds a B.S. in Physiology and Biochemistry from Reading University and a Ph.D. in Biochemistry from London University.
As the Lead Independent Director of Luminex Corp, the total compensation of Edward Ogunro at Luminex Corp is 178,984$. There are 7 executives at Luminex Corp getting paid more, with Nachum Shamir having the highest compensation of 3,362,140$.
Edward Ogunro is 67, he's been the Lead Independent Director of Luminex Corp since 2020. There are 1 older and 12 younger executives at Luminex Corp. The oldest executive at Luminex Corp is Thomas Erickson, 69, who is the Independent Director.
Edward's mailing address filed with the SEC is 12212 TECHNOLOGY BOULEVARD, , AUSTIN, TX, 78727.
Over the last 21 years, insiders at Luminex Corp have traded over 55,627,864$ worth of Luminex Corp stock and bought 685,936 units worth 10,423,148$ . The most active insiders traders include G Walter Ii Loewenbaum、Douglas C Bryant、Laurence E Hirsch. On average, Luminex Corp executives and independent directors trade stock every 26 days with the average trade being worth of 888,944$. The most recent stock trade was executed by Harriss T Currie on 1 March 2021, trading 5,325 units of LMNX stock currently worth 97,235$.
The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.
Luminex Corp executives and other stock owners filed with the SEC include: